2008Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhiRequires access

Effect of CpG oligodeoxynucleotides on airway inflammation and transcription factor GATA-3 mRNA expression in asthmatic mice

Shuyang Zhu

Open publisher page 0 citations

Abstract

[Objective] To investigate the effect of CpG oligodeoxynucleotides(CpG ODN) on airway inflammation and transcription factor GATA-3 mRNA expression in asthmatic mice.[Methods] Fourty female BALB/C mice were randomly divided into four groups(10 mice in each group): saline control group(group A); asthmatic group(group B); CpG ODN intervention group (group C); GpC ODN control group(group D). Mice were sensitized by intraperitoneally injection of OVA/alum on days 0, 7, 14, and 21, and subsequently received nebulized 2% OVA on days 25, 26, 27 and 28. Groups C and D were treated with CpG ODN or GpC ODN(50 μg/mouse) intraperitoneally 24 h before OVA inhalation challenges. All the mice were killed 24 h after the final OVA challenge, bronchoalveolar lavage fluid (BALF)were collected for counting total inflammatory cells and the percentage of eosinophils, IFN-γ, IL-4 and IL-5concentrations in BALF were detected using an enzyme-linked immunosorbent assay, transcription factor GATA-3 mRNA expression in lung tissue was detected by reverse transcription-polymerase chain reaction. [Results] The total inflammatory cells, percentage of eosinophils, concentrations of IL-4, IL-5 and IFN-γ in BALF in each group were as follows: in group A they were (7.46±1.77)×105/mL, (0.75±0.48)%, (26.9±4.6)pg/mL, (41.7±5.1)pg/mL, (110.4±12.1)pg/mL respectively; in group B they were (21.68±4.40)×105/mL, (9.50±1.13)%, (267.6±24.5)pg/mL, (218.2±15.2)pg/mL, (47.9±9.6)pg/mL respectively; in group C they were (8.98±2.23)×105/mL, (2.90±0.86)%, (85.9± 8.1)pg/mL, (63.0±9.6)pg/mL, (221.0±29.9)pg/mL respectively; in group D they were (20.41±3.47)×105/mL, (9.60±1.30)%, (260.7± 15.7)pg/mL, (205.1±15.8)pg/mL, (52.2±10.7)pg/mL respectively. Group B was significantly different from group A(P 0.01), group C was significantly different from group B(P 0.01), group D was not significantly different from group C(P 0.05). The GATA-3 mRNA expression was reduced in lung tissue in group C compared with group B, group C was obviously different from group B(P 0.01), but there was no difference between group D and group B(P 0.05).[Conclusions] This study suggests that CpG ODN could inhibit production of Th2 cytokines, down-regulate GATA-3 mRNA expression, and relieve the allergic inflammation of airway in asthmatic mice.

About this research paper

What this paper is about

[Objective] To investigate the effect of CpG oligodeoxynucleotides(CpG ODN) on airway inflammation and transcription factor GATA-3 mRNA expression in asthmatic mice.[Methods] Fourty female BALB/C mice were randomly divided into four groups(10 mice in each group): saline control group(group A); asthmatic group(group B); CpG ODN intervention group (group C); GpC ODN control group(group D). Mice were sensitized by intraperitoneally injection of OVA/alum on days 0, 7, 14, and 21, and subsequently received nebulized 2% OVA on days 25, 26, 27 and 28. Groups C and D were treated with CpG ODN or GpC ODN(50 μg/mouse) intraperitoneally 24 h before OVA inhalation challenges. All the mice were killed 24 h after the final OVA challenge, bronchoalveolar lavage fluid (BALF)were collected for counting total inflammatory cells and the percentage of eosinophils, IFN-γ, IL-4 and IL-5concentrations in BALF were detected using an enzyme-linked immunosorbent assay, transcription factor GATA-3 mRNA expression in lung tissue was detected by reverse transcription-polymerase chain reaction. [Results] The total inflammatory cells, percentage of eosinophils, concentrations of IL-4, IL-5 and IFN-γ in BALF in each group were as follows: in group A they were (7.46±1.77)×105/mL, (0.75±0.48)%, (26.9±4.6)pg/mL, (41.7±5.1)pg/mL, (110.4±12.1)pg/mL respectively; in group B they were (21.68±4.40)×105/mL, (9.50±1.13)%, (267.6±24.5)pg/mL, (218.2±15.2)pg/mL, (47.9±9.6)pg/mL respectively; in group C they were (8.98±2.23)×105/mL, (2.90±0.86)%, (85.9± 8.1)pg/mL, (63.0±9.6)pg/mL, (221.0±29.9)pg/mL respectively; in group D they were (20.41±3.47)×105/mL, (9.60±1.30)%, (260.7± 15.7)pg/mL, (205.1±15.8)pg/mL, (52.2±10.7)pg/mL respectively. Group B was significantly different from group A(P 0.01), group C was significantly different from group B(P 0.01), group D was not significantly different from group C(P 0.05). The GATA-3 mRNA expression was reduced in lung tissue in group C compared with group B, group C was obviously different from group B(P 0.01), but there was no difference between group D and group B(P 0.05).[Conclusions] This study suggests that CpG ODN could inhibit production of Th2 cytokines, down-regulate GATA-3 mRNA expression, and relieve the allergic inflammation of airway in asthmatic mice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To investigate the effect of CpG oligodeoxynucleotides(CpG ODN) on airway inflammation and transcription factor GATA-3 mRNA expression in asthmatic mice.[Methods] Fourty female BALB/C mice were randomly divided into four groups(10 mice in each group): saline control group(group A); asthmatic group(group B); CpG ODN intervention group (group C); GpC ODN control group(group D). Mice were sensitized by intraperitoneally injection of OVA/alum on days 0, 7, 14, and 21, and subsequently received nebulized 2% OVA on days 25, 26, 27 and 28. Groups C and D were treated with CpG ODN or GpC ODN(50 μg/mouse) intraperitoneally 24 h before OVA inhalation challenges. All the mice were killed 24 h after the final OVA challenge, bronchoalveolar lavage fluid (BALF)were collected for counting total inflammatory cells and the percentage of eosinophils, IFN-γ, IL-4 and IL-5concentrations in BALF were detected using an enzyme-linked immunosorbent assay, transcription factor GATA-3 mRNA expression in lung tissue was detected by reverse transcription-polymerase chain reaction. [Results] The total inflammatory cells, percentage of eosinophils, concentrations of IL-4, IL-5 and IFN-γ in BALF in each group were as follows: in group A they were (7.46±1.77)×105/mL, (0.75±0.48)%, (26.9±4.6)pg/mL, (41.7±5.1)pg/mL, (110.4±12.1)pg/mL respectively; in group B they were (21.68±4.40)×105/mL, (9.50±1.13)%, (267.6±24.5)pg/mL, (218.2±15.2)pg/mL, (47.9±9.6)pg/mL respectively; in group C they were (8.98±2.23)×105/mL, (2.90±0.86)%, (85.9± 8.1)pg/mL, (63.0±9.6)pg/mL, (221.0±29.9)pg/mL respectively; in group D they were (20.41±3.47)×105/mL, (9.60±1.30)%, (260.7± 15.7)pg/mL, (205.1±15.8)pg/mL, (52.2±10.7)pg/mL respectively. Group B was significantly different from group A(P 0.01), group C was significantly different from group B(P 0.01), group D was not significantly different from group C(P 0.05). The GATA-3 mRNA expression was reduced in lung tissue in group C compared with group B, group C was obviously different from group B(P 0.01), but there was no difference between group D and group B(P 0.05).[Conclusions] This study suggests that CpG ODN could inhibit production of Th2 cytokines, down-regulate GATA-3 mRNA expression, and relieve the allergic inflammation of airway in asthmatic mice.

Key concepts: Bronchoalveolar lavage, CpG Oligodeoxynucleotide, Immunology, Reverse transcription polymerase chain reaction, Inflammation, Molecular biology, Saline, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of CpG oligodeoxynucleotides on airway inflammation and transcription factor GATA-3 mRNA expression in asthmatic mice — Research Paper | ScholarLens